ESYA Labs Partners with Alamar Biosciences to Advance Biomarker Detection and Diagnostics for Neurological Diseases
ESYA Labs, a global leader in lysosomal biology and biomarker discovery for neurodegenerative diseases, has announced a transformative partnership with Alamar Biosciences, a pioneer in ultra-sensitive immunoassay technologies. By merging their respective strengths, the collaboration aims to revolutionise the detection and quantification of biomarkers for neurological and inflammatory diseases, using Alamar’s NULISA™ platform and ARGO™ HT System. These advanced technologies will be made available through ESYA’s cutting-edge laboratory in Dallas, Texas.
